Pangea Biomed
Pangea Biomed, founded in 2018, is a precision oncology company that combines advanced molecular biology, bioinformatics, and machine learning to revolutionize cancer care. Its proprietary ENLIGHT platform analyzes tumor biology beyond genomic mutations by integrating expression abnormalities, epigenetics, and proteomics to uncover tumor vulnerabilities and improve drug discovery and personalized treatment nomination. The company collaborates with leading medical institutions and research labs, aiming to accelerate drug development and enhance clinical outcomes through deep tumor intelligence. Pangea's multidisciplinary team includes world-renowned cancer researchers and experts in biology, data science, and computational methods, positioning it as an innovative leader in precision oncology.
Pangea Biomed
Pangea Biomed, founded in 2018, is a precision oncology company that combines advanced molecular biology, bioinformatics, and machine learning to revolutionize cancer care. Its proprietary ENLIGHT platform analyzes tumor biology beyond genomic mutations by integrating expression abnormalities, epigenetics, and proteomics to uncover tumor vulnerabilities and improve drug discovery and personalized treatment nomination. The company collaborates with leading medical institutions and research labs, aiming to accelerate drug development and enhance clinical outcomes through deep tumor intelligence. Pangea's multidisciplinary team includes world-renowned cancer researchers and experts in biology, data science, and computational methods, positioning it as an innovative leader in precision oncology.